Clinical Trial Update: Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and effectiveness of fenofibrate and pravastatin in HIV-positive patients with abnormal blood lipids; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Lipodystrophy

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Pravastatin (pravastatin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Lipodystrophy | Phase 3 | Status: COMPLETED